Daily news
Using evidence as the guiding star, the @ducrest Twitter timeline consists of the latest scientific publications in dermatology, cosmetic dermatology, cosmetics and Home-Use devices. Here you will find interesting information gleaned from science and technology sources as well as the lay press.
RT @itchdoctor: I want to generate a new in vivo blocking monoclonal antibody for use in mice. Does anyone have a great CRO they can recomm…
RT @ducrest: Skin & Digital Summit – 10 December 2022 linkedin.com/pulse/skin-dig…
V. Grateful to @miriazolam @JohnZibert @HaraldKittler @jk_a…
Skin & Digital Summit – 10 December 2022 linkedin.com/pulse/skin-dig…
V. Grateful to @miriazolam @JohnZibert…
https://twitter.com/i/web/status/1586253582655172609
RT @derm_scientist: Apply now – a great opportunity with a closing date in Jan 2023 @skinucph @LEOFondet #dermtwitter https://t.co/ZrsVYOQQ…
RT @kellymkimball: Our next @DermTalks lecture will be this Monday, October 31st, and will feature @drshawnkwatra from @JohnsHopkins. He wi…
Itch assessments – interesting @JAMADerm article
1/ Peak 24-hour numeric rating scale (NRS)-itch
2/ One-week NRS-it…
https://twitter.com/i/web/status/1585886856691982339
#skincancer -As in 2016 The U.S. Preventive Services Task Force (USPSTF) concludes there is currently insufficient…
https://twitter.com/i/web/status/1585529550674477056
RT @JAMADerm: Does low dose methotrexate increase the risk of melanoma? Yes BUT the risk is low. In Australia, where melanoma is common, 18…
@RoxanaDaneshjou Just wondering when such limitations remain!!